These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9009652)

  • 1. In vitro susceptibility of Malassezia furfur against azole compounds.
    Schmidt A; Rühl-Hörster B
    Mycoses; 1996; 39(7-8):309-12. PubMed ID: 9009652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Malassezia furfur.
    Schmidt A; Rühl-Hörster B
    Arzneimittelforschung; 1996 Apr; 46(4):442-4. PubMed ID: 8740097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.
    Van Gerven F; Odds FC
    Mycoses; 1995; 38(9-10):389-93. PubMed ID: 8569815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of climbazole, clotrimazole and silver-sulphadiazine against isolates of Malassezia pachydermatis.
    Schmidt A
    Zentralbl Veterinarmed B; 1997 Jun; 44(4):193-7. PubMed ID: 9230670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology,
    Li W; Zhang ZW; Luo Y; Liang N; Pi XX; Fan YM
    J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
    [No Abstract]   [Full Text] [Related]  

  • 8. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
    Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
    Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
    Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
    Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel cosmetic shampoo formulations against Malassezia species: Preliminary results of anti-dandruff shampoo formulations.
    Ergin Ç; Kurt Ö; Türkoğlu M; Sevinç H; Akbaba G
    J Cosmet Dermatol; 2024 Jun; 23(6):2078-2083. PubMed ID: 38544350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antifungal activity of amorolfine against Malassezia species].
    Uchida K; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1013-9. PubMed ID: 1960851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
    Far FE; Al-Obaidi MMJ; Desa MNM
    J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chlorogenic and gallic acids combined with azoles on antifungal susceptibility and virulence of multidrug-resistant Candida spp. and Malassezia furfur isolates.
    Rhimi W; Aneke CI; Annoscia G; Otranto D; Boekhout T; Cafarchia C
    Med Mycol; 2020 Nov; 58(8):1091-1101. PubMed ID: 32236482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
    Sancak B; Ayhan M; Karaduman A; Arikan S
    Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest
    Galvis-Marín JC; Rodríguez-Bocanegra MX; Pulido-Villamarín ADP; Castañeda-Salazar R; Celis-Ramírez AM; Linares-Linares MY
    Rev Iberoam Micol; 2017; 34(2):89-93. PubMed ID: 28214276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An azole-resistant isolate of Malassezia pachydermatis.
    Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
    Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.
    Youngchim S; Nosanchuk JD; Chongkae S; Vanittanokom N
    Arch Dermatol Res; 2017 Jan; 309(1):47-53. PubMed ID: 27885419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.
    Carrillo-Muñoz AJ; Rojas F; Tur-Tur C; de Los Ángeles Sosa M; Diez GO; Espada CM; Payá MJ; Giusiano G
    Mycoses; 2013 Sep; 56(5):571-5. PubMed ID: 23496653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
    Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
    Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
    Zissova LG; Kantarjiev TB; Kuzmanov AH
    Folia Med (Plovdiv); 2001; 43(3):10-2. PubMed ID: 11930825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.